Biotechnology
| Tue 22 Sep 2026
Alexandria, Sept. 22 -- Eli Lilly And Co has obtained a patent for macrocyclic glucagon-like peptide 1 receptor agonists. This invention was developed by Agejas Chicharro Francisco Javier, Rodriguez Hergueta Antonio, Bauer Renato Alejandro, Gernert Douglas Linn, Masquelin Thierry Jean, Chen Qi, Cumming Graham Robert, Ho Joseph D..